Search results
Sanofi Stock Crashes 19% As Drugmaker's Third Quarter Comes In Light Ahead Of Spinoff
Investor's Business Daily· 7 months agoSanofi stock crashed Friday after the drugmaker missed Wall Street's third-quarter expectations and...
Drugmaker Mallinckrodt files for second bankruptcy in US
Reuters via Yahoo News· 9 months agoDrugmaker Mallinckrodt on Monday filed for its second bankruptcy in three years in the United...
Stocks End April On Sour Note, Dow Loses 570 Points
Investor's Business Daily· 1 month agoStocks ended April in a tailspin Tuesday with the major indexes down between 1.5% and 2% for the month's last trading session. Meanwhile, Amazon.com...
How Novartis' Laggard Business Was Its Second-Quarter Saving Grace
Investor's Business Daily· 2 years agoSwiss drugmaker Novartis delivered a mixed second-quarter report Tuesday, but Novartis stock popped...
2 Breakout Growth Stocks to Buy for the Long Haul
Motley Fool· 1 year agoAs a result, it's never a bad idea to consider buying equities with strong forward momentum. Here are two healthcare stocks that have been breaking out...
Novo Nordisk Surges To Another Record As Obesity Drugs Drive Higher Outlook
Investor's Business Daily· 1 year agoNovo Nordisk stock forged ahead to another new high Thursday after the Danish drugmaker raised its...
Merck Nabs Prometheus Bio For $10.8 Billion As Keytruda Patent Expirations Loom
Investor's Business Daily· 1 year agoMerck is acquiring immunology-focused drugmaker Prometheus Bio in a well-timed $10.8 billion deal...
Cathie Wood Is Buying This Growth Stock Hand Over Fist Lately. Should You Follow Her Lead?
Motley Fool· 8 months agoThis September, Cathie Wood bought shares of Beam Therapeutics (NASDAQ: BEAM) more than a dozen...
Novartis' Sandoz dips on debut after lower than expected valuation
Reuters via Yahoo News· 8 months ago(Reuters) -Sandoz shares dipped on their market debut on Wednesday after the generic and biosimilar...
Billionaires Loaded Up on These 3 Stocks in the Fourth Quarter of 2022
Motley Fool· 1 year agoU.S. stock markets were in turmoil in 2022. A perfect storm of rampant inflation, global supply...